$JRSS
JRSIS HEALTH CARE Corp Stock $jrss

$jrss Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000121390024047342 Filed on May 29, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023 Q1
Revenue	$500.4K	$3.405M
YoY Change		3718.6%
Cost Of Revenue	$443.2K	$2.979M	$325.6K
YoY Change	36.12%		-90.22%
Gross Profit	$57.22K	$426.2K	$151.4K
YoY Change	-62.2%		-98.77%
Gross Profit Margin	11.43%	12.52%
Selling, General & Admin	$207.9K	$482.4K	$113.5K
YoY Change	83.2%	278.43%	-96.96%
% of Gross Profit	363.28%	113.19%	74.95%
Research & Development	$10.25K	$189.3K	$30.30K
YoY Change	-66.15%
% of Gross Profit	17.92%	44.41%	20.01%
Depreciation & Amortization	$3.010K	$43.82K	$2.138K
YoY Change	40.79%	1957.28%	-99.76%
% of Gross Profit	5.26%	10.28%	1.41%
Operating Expenses	$218.1K	$271.5K	$119.2K
YoY Change	83.05%	104.13%	-98.57%
Operating Profit	-$160.9K	$154.7K	-$119.2K
YoY Change	35.03%		-102.99%
Interest Expense	$11.91K	-$53.38K
YoY Change
% of Operating Profit		-34.51%
Other Income/Expense, Net	-$9.042K	$156.4K	$81.82K
YoY Change	-111.05%	-9086.78%	-1312.16%
Pretax Income	-$169.9K	$257.7K	-$119.2K
YoY Change	42.62%	-665.61%	-103.34%
Income Tax		$8.980K
% Of Pretax Income		3.48%
Net Earnings	-$145.4K	$262.4K	-$119.2K
YoY Change	21.98%	-675.92%	-106.45%
Net Earnings / Revenue	-29.05%	7.71%
Basic Earnings Per Share	$0.00		$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	84.33M shares	5.837M shares	58.37M shares
Diluted Shares Outstanding	84.33M shares		58.37M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$323.6K	$118.1K	$18.78K
YoY Change	1623.16%	101.48%	-99.04%
Cash & Equivalents	$323.6K	$118.1K	$18.78K
Short-Term Investments
Other Short-Term Assets	$316.8K	$420.1K	$654.6K
YoY Change	-51.6%	-42.96%	-85.81%
Inventory	$445.5K	$455.2K
Prepaid Expenses
Receivables	$603.0K	$714.7K
Other Receivables	$26.47K	$4.730K	$2.999K
Total Short-Term Assets	$1.816M	$1.834M	$676.3K
YoY Change	168.47%	129.57%	-96.06%
LONG-TERM ASSETS
Property, Plant & Equipment	$46.19K	$50.02K	$37.03K
YoY Change	24.75%	28.3%	-99.94%
Goodwill
YoY Change
Intangibles	$243.9K	$257.3K
YoY Change		-15.13%
Long-Term Investments
YoY Change
Other Assets		$0.00
YoY Change
Total Long-Term Assets	$292.3K	$310.6K	$52.52K
YoY Change	456.51%	443.76%	-99.92%
TOTAL ASSETS
Total Short-Term Assets	$1.816M	$1.834M	$676.3K
Total Long-Term Assets	$292.3K	$310.6K	$52.52K
Total Assets	$2.108M	$2.145M	$728.9K
YoY Change	189.23%	150.54%	-99.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$563.7K	$801.3K	$20.00K
YoY Change	2718.6%	3142.64%	-99.86%
Accrued Expenses	$73.25K	$114.8K	$16.97K
YoY Change	331.64%	519.65%	-99.08%
Deferred Revenue		$218.3K
YoY Change
Short-Term Debt	$1.368M	$983.0K	$0.00
YoY Change			-100.0%
Long-Term Debt Due	$24.53K	$18.71K
YoY Change		-62.35%
Total Short-Term Liabilities	$2.397M	$2.280M	$36.97K
YoY Change	6383.84%	5174.52%	-99.82%
LONG-TERM LIABILITIES
Long-Term Debt	$18.40K	$24.95K	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Long-Term Liabilities	$18.40K	$24.95K	$0.00
YoY Change		1644.76%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.397M	$2.280M	$36.97K
Total Long-Term Liabilities	$18.40K	$24.95K	$0.00
Total Liabilities	$2.415M	$2.305M	$36.97K
YoY Change	6433.62%	5061.5%	-99.94%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.588M	-$3.443M	-$23.82M
YoY Change	-84.94%	-85.48%
Common Stock	$8.460K	$8.259K	$58.37K
YoY Change	-85.51%	-85.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$259.9K	-$137.4K	$691.9K
YoY Change
Total Liabilities & Shareholders Equity	$2.108M	$2.145M	$728.9K
YoY Change	189.23%	150.54%	-99.1%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023 Q1
OPERATING ACTIVITIES
Net Income	-$145.4K	$262.4K	-$119.2K
YoY Change	21.98%	-675.92%	-106.45%
Depreciation, Depletion And Amortization	$3.010K	$43.82K	$2.138K
YoY Change	40.79%	1957.28%	-99.76%
Cash From Operating Activities	-$204.9K	$536.7K	-$36.51K
YoY Change	461.32%	697.15%	-100.79%
INVESTING ACTIVITIES
Capital Expenditures		$1.480K
YoY Change		-185.55%
Acquisitions
YoY Change
Other Investing Activities		$20.37K	$0.00
YoY Change			-100.0%
Cash From Investing Activities		$18.89K
YoY Change		998.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$413.3K	-568.4K
YoY Change
NET CHANGE
Cash From Operating Activities	-$204.9K	536.7K	-$36.51K
Cash From Investing Activities		18.89K
Cash From Financing Activities	$413.3K	-568.4K
Net Change In Cash	$205.5K	-12.76K	-$39.84K
YoY Change	-615.82%	-118.48%	-104.12%
FREE CASH FLOW
Cash From Operating Activities	-$204.9K	$536.7K	-$36.51K
Capital Expenditures		$1.480K
Free Cash Flow	-$204.9K	$535.2K	-$36.51K
YoY Change	461.32%	675.04%	-100.63%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	76757439	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	84334314	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.002
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	0-56013
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	JRSIS HEALTH CARE CORPORATION
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-4562047
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	Building 2, Youth Innovation and Entrepreneurship Park
CY2024Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Xiaoxiang Science and Technology Innovation Center
CY2024Q1	dei	Entity Address Address Line3 EntityAddressAddressLine3	Yongzhou Economic and Technology Development Zone
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Hunan Province
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	425000
CY2024Q1	dei	Entity Address Country EntityAddressCountry	CN
CY2024Q1	dei	City Area Code CityAreaCode	+86
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	760-88963658
CY2024Q1	dei	Security12b Title Security12bTitle	Common stock, $0.0001 par value
CY2024Q1	dei	No Trading Symbol Flag NoTradingSymbolFlag	true
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	84598650	shares
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	323611	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	118114	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	603022	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	714658	usd
CY2024Q1	us-gaap	Supplies Supplies	251404	usd
CY2023Q4	us-gaap	Supplies Supplies	345961	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	445500	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	455240	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	89278	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	77211	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	1815822	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1833890	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	46193	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	50024	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	243897	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	257334	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2161	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3277	usd
CY2024Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	292251	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	310635	usd
CY2024Q1	us-gaap	Assets Assets	2108073	usd
CY2023Q4	us-gaap	Assets Assets	2144525	usd
CY2024Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	1368261	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	983007	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	24534	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	18713	usd
CY2024Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	496793	usd
CY2023Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	540086	usd
CY2024Q1	jrss	Advances From Customers AdvancesFromCustomers	223121	usd
CY2023Q4	jrss	Advances From Customers AdvancesFromCustomers	218313	usd
CY2024Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	39552	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	18845	usd
CY2024Q1	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	169938	usd
CY2023Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	221869	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2161	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3277	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2396947	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2280227	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	18401	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	24950	usd
CY2024Q1	us-gaap	Liabilities Liabilities	2415348	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2305177	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	84598650	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	84598650	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	82594105	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	82594105	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	8460	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	8259	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3174217	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3154373	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3588254	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3442898	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	145644	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	142860	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-259933	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-137406	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	-47342	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-23246	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-307275	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-160652	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2108073	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2144525	usd
CY2024Q1	us-gaap	Revenues Revenues	500420	usd
CY2023Q1	us-gaap	Revenues Revenues	476994	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	443198	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	325602	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	57222	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	151392	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	106762	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	12341	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	101112	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	31232	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10254	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	30295	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	218128	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	73868	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-160906	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	77524	usd
CY2024Q1	us-gaap	Interest Income Other InterestIncomeOther	67	usd
CY2023Q1	us-gaap	Interest Income Other InterestIncomeOther	303	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	11906	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	19738	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2797	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3329	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9042	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-16106	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-169948	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	61418	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8283	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-169948	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	53135	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-24592	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	7689	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-145356	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	45446	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-169948	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	53135	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	3280	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-487	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-166668	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	52648	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-24096	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	7619	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-142572	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	45029	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	84334314	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	76757439	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.002
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.001
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-68343	usd
CY2023	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	75	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-94588	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	2204	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-160652	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	20045	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-169948	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	3280	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-307275	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-169948	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	53135	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	12197	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	14403	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1066	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1064	usd
CY2024Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	25	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	77	usd
CY2024Q1	jrss	Inventories Impairment Return InventoriesImpairmentReturn	-412	usd
CY2023Q1	jrss	Inventories Impairment Return InventoriesImpairmentReturn	-6202	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4613	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-100160	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-246259	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-18773	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	144085	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Supplies IncreaseDecreaseInPrepaidSupplies	-89181	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Supplies IncreaseDecreaseInPrepaidSupplies	62688	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2571	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	145871	usd
CY2024Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	13414	usd
CY2023Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	524	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-34439	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-14903	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-190763	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	37374	usd
CY2024Q1	jrss	Increase Decreasein Advances From Customers IncreaseDecreaseinAdvancesFromCustomers	8486	usd
CY2023Q1	jrss	Increase Decreasein Advances From Customers IncreaseDecreaseinAdvancesFromCustomers	-3136	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	21115	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-12680	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1091	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-2287	usd
CY2024Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-48444	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	18944	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-204937	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16507	usd
CY2024Q1	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	20045	usd
CY2024Q1	jrss	Proceeds From Financing Lease ProceedsFromFinancingLease	403422	usd
CY2023Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	166210	usd
CY2024Q1	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-10200	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	23035	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	413267	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-143175	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-2833	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5507	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	205497	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-154175	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	118114	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	158813	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	323611	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4638	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	957	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1447	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	11898	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	16569	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	5392000	shares
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-169948	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3588254	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-204937	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16507	usd
CY2024Q1	jrss	Working Capital Deficit WorkingCapitalDeficit	581125	usd
CY2024Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>●</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Reclassification</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Certain prior period balances were reclassified to conform to the current period presentation, mainly with consideration of reflecting the acquisition transaction by entering into and executing four agreements with Yongzhou Jumi Intelligent Technology Co., Ltd. (“Yongzhou JIT”) and Guangzhou Jumi Intelligent Equipment Co., Ltd. (“Guangzhou JIE”). None of these reclassifications had an impact on reported financial position or cash flows for any of the periods presented.</span></p>
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>●</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Use of Estimates</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The preparation of the unaudited consolidated financial statements in conformity with US GAAP requires management to make estimates and judgments that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities on the date of the unaudited consolidated financial statements and the reported amounts of revenue and expenses during the reporting period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company bases its estimates and judgments on historical experience and on various other assumptions and information that are believed to be reasonable under the circumstances. Estimates and assumptions of future events and their effects cannot be perceived with certainty and, accordingly, these estimates may change as new events occur, as more experience is acquired, as additional information is obtained and as our operating environment changes. Estimates and assumptions are periodically reviewed and the effects of revisions are reflected in the consolidated financial statements in the period they are determined to be necessary.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Significant estimates and assumptions made by management include, among others, useful lives and impairment of long-lived assets, collectability of accounts receivable, discount rate of leases and its impairment assessment, allowance for inventory, revenue recognition, product warranty liabilities, deferred tax and uncertain tax positions. While the Company believes that the estimates and assumptions used in the preparation of the consolidated financial statements are appropriate, actual results could differ from those estimates.</span></p>
CY2024Q1	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	7.2203	pure
CY2023Q1	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	6.8676	pure
CY2024Q1	us-gaap	Foreign Currency Exchange Rate Remeasurement1 ForeignCurrencyExchangeRateRemeasurement1	7.1885	pure
CY2023Q1	us-gaap	Foreign Currency Exchange Rate Remeasurement1 ForeignCurrencyExchangeRateRemeasurement1	6.8423	pure
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q1	us-gaap	Advertising Expense AdvertisingExpense	97754	usd
CY2024Q1	us-gaap	Advertising Expense AdvertisingExpense	0	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10254	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	30295	usd
CY2024Q1	us-gaap	Income Tax Examination Likelihood Of Unfavorable Settlement IncomeTaxExaminationLikelihoodOfUnfavorableSettlement	the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement
CY2024Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	603022	usd
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	714658	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	603022	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	714658	usd
CY2024Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	303197	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	302322	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	69773	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	128900	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	257326	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	212364	usd
CY2024Q1	us-gaap	Inventory Gross InventoryGross	630296	usd
CY2023Q4	us-gaap	Inventory Gross InventoryGross	643586	usd
CY2024Q1	us-gaap	Inventory Adjustments InventoryAdjustments	184796	usd
CY2023Q4	us-gaap	Inventory Adjustments InventoryAdjustments	188346	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	445500	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	455240	usd
CY2024Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	20632	usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	20981	usd
CY2024Q1	jrss	Advances To Personnel AdvancesToPersonnel	1385	usd
CY2023Q4	jrss	Advances To Personnel AdvancesToPersonnel	1408	usd
CY2024Q1	jrss	Vat Deductible VATDeductible	-64054	usd
CY2023Q4	jrss	Vat Deductible VATDeductible	-51714	usd
CY2024Q1	us-gaap	Other Receivables OtherReceivables	3207	usd
CY2023Q4	us-gaap	Other Receivables OtherReceivables	3108	usd
CY2024Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	89278	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	77211	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	89278	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	77211	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	145115	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	147576	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	98922	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	97552	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	46193	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	50024	usd
CY2024Q1	us-gaap	Depreciation Depreciation	3010	usd
CY2023Q1	us-gaap	Depreciation Depreciation	4752	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	365845	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	372049	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-121948	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-114715	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	243897	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	257334	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	9187	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	9651	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	36584	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	36584	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	36584	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	36584	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	36584	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	60977	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	243897	usd
CY2022Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P30D
CY2022Q4	us-gaap	Operating Lease Payments OperatingLeasePayments	369	usd
CY2022Q4	us-gaap	Operating Lease Payments OperatingLeasePayments	2615	cny
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2161	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3277	usd
CY2024Q1	us-gaap	Other Assets OtherAssets	2161	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	3277	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2161	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3277	usd
CY2024Q1	jrss	Leases Liabilities Net LeasesLiabilitiesNet	2161	usd
CY2023Q4	jrss	Leases Liabilities Net LeasesLiabilitiesNet	3277	usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	1091	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	1147	usd
CY2024Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	19332	usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	20310	usd
CY2024Q1	us-gaap	Lease Cost LeaseCost	20423	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	21457	usd
CY2024Q1	jrss	Operating Cash Flows From Operating Leases OperatingCashFlowsFromOperatingLeases	-1091	usd
CY2023Q1	jrss	Operating Cash Flows From Operating Leases OperatingCashFlowsFromOperatingLeases	-2293	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y5M1D
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y9M
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0475	pure
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0475	pure
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2173	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2173	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	12	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2161	usd
CY2024Q1	us-gaap	Revenues Revenues	500420	usd
CY2023Q1	us-gaap	Revenues Revenues	476994	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	443198	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	325602	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	57222	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	151392	usd
CY2023	jrss	Long Term Debt Borrowings LongTermDebtBorrowings	310000	cny
CY2024Q1	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	11898	usd
CY2023Q1	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	16569	usd
CY2024Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	47126	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	58243	usd
CY2024Q1	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	11069	usd
CY2023Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	9720	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	169938	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	221869	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	-47342	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-23246	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-142572	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-24096	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	45029	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	7619	usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4879075	usd
CY2024Q1	jrss	Unified Income Tax Rate UnifiedIncomeTaxRate	0.25	pure
CY2024Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-169950	usd
CY2023Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	61421	usd
CY2024Q1	jrss	Effective Income Tax Rate Reconcilation Statutory Income Tax Rate EffectiveIncomeTaxRateReconcilationStatutoryIncomeTaxRate	0.25	pure
CY2023Q1	jrss	Effective Income Tax Rate Reconcilation Statutory Income Tax Rate EffectiveIncomeTaxRateReconcilationStatutoryIncomeTaxRate	0.25	pure
CY2024Q1	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	42487	usd
CY2023Q1	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-15355	usd
CY2023Q1	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-4518	usd
CY2023Q1	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	11590	usd
CY2024Q1	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-42487	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8283	usd
CY2024Q1	jrss	Value Added Tax Payable ValueAddedTaxPayable	39126	usd
CY2023Q4	jrss	Value Added Tax Payable ValueAddedTaxPayable	15830	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	969	usd
CY2023Q4	jrss	Withholding Personal Tax WithholdingPersonalTax	176	usd
CY2024Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	426	usd
CY2023Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	1870	usd
CY2024Q1	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	39552	usd
CY2023Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	18845	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-145356	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	45446	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	84334314	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	76757439	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.002
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q1	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	1462	usd
CY2023Q1	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	1442	usd
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2024Q1	jrss	After Tax Net Income Percentage AfterTaxNetIncomePercentage	0.10	pure
CY2024Q1	jrss	Percentage Of Reserve Capital PercentageOfReserveCapital	0.50	pure
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent		usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent		usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2024Q1	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated		usd
CY2023Q4	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated		usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2024Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2023Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023Q1	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital		usd
CY2023Q1	jrss	Proceeds From Financing Lease ProceedsFromFinancingLease		usd
CY2024Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt		usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2024Q1	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent		usd
CY2023Q4	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent		usd
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent		usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent		usd
CY2024Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2024Q1	jrss	Finance Lease Cost FinanceLeaseCost		usd
CY2023Q1	jrss	Finance Lease Cost FinanceLeaseCost		usd
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization		usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization		usd
CY2024Q1	us-gaap	Sublease Income SubleaseIncome		usd
CY2023Q1	us-gaap	Sublease Income SubleaseIncome		usd
CY2024Q1	us-gaap	Sale And Leaseback Transaction Gain Loss Net SaleAndLeasebackTransactionGainLossNet		usd
CY2023Q1	us-gaap	Sale And Leaseback Transaction Gain Loss Net SaleAndLeasebackTransactionGainLossNet		usd
CY2024Q1	jrss	Operating Cash Flows From Finance Leases OperatingCashFlowsFromFinanceLeases		usd
CY2023Q1	jrss	Operating Cash Flows From Finance Leases OperatingCashFlowsFromFinanceLeases		usd
CY2024Q1	jrss	Financing Cash Flow From Finance Leases FinancingCashFlowFromFinanceLeases		usd
CY2023Q1	jrss	Financing Cash Flow From Finance Leases FinancingCashFlowFromFinanceLeases		usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability		usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability		usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2024Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1
CY2023Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1
CY2024Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent		pure
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent		pure
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo		usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree		usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour		usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive		usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive		usd
CY2024Q1	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense		usd
CY2024Q1	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome		usd
CY2023Q1	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance		usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent		usd
CY2024Q1	jrss	Withholding Personal Tax WithholdingPersonalTax		usd
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	76757439	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	84334314	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.001
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.002
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001597892

Files In Submission

Name	View Source	Status
0001213900-24-047342-index-headers.html	Edgar Link	pending
0001213900-24-047342-index.html	Edgar Link	pending
0001213900-24-047342.txt	Edgar Link	pending
0001213900-24-047342-xbrl.zip	Edgar Link	pending
ea0206897-10q_jrsis.htm	Edgar Link	pending
ea020689701ex31-1_jrsis.htm	Edgar Link	pending
ea020689701ex31-2_jrsis.htm	Edgar Link	pending
ea020689701ex32-1_jrsis.htm	Edgar Link	pending
ea020689701ex32-2_jrsis.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
jrss-20240331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
jrss-20240331_cal.xml	Edgar Link	unprocessable
jrss-20240331_lab.xml	Edgar Link	unprocessable
jrss-20240331_pre.xml	Edgar Link	unprocessable
ea0206897-10q_jrsis_htm.xml	Edgar Link	completed
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
jrss-20240331_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$JRSS
JRSIS HEALTH CARE Corp Stock $jrss

2024 Q1 Form 10-Q Financial Statement

#000121390024047342 Filed on May 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JRSS JRSIS HEALTH CARE Corp Stock $jrss

2024 Q1 Form 10-Q Financial Statement

#000121390024047342 Filed on May 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JRSS
JRSIS HEALTH CARE Corp Stock $jrss